Since previous studies suggest that circulating EPC populations and type I IFNs could be involved in increasing cardiovascular risk in autoimmune diseases, the main aim of this study is to determine EPCs frequency in RA patients’ peripheral blood and evaluate the potential associations with IFNα serum levels and clinical and immunological features. The gene discussed is IFNA1; the disease is autoimmune disease.